DK1343480T3 - Induceret faseovergangsmetode til fremstilling af mikropartikler indeholdende hydrofobe aktive midler - Google Patents

Induceret faseovergangsmetode til fremstilling af mikropartikler indeholdende hydrofobe aktive midler

Info

Publication number
DK1343480T3
DK1343480T3 DK01992358T DK01992358T DK1343480T3 DK 1343480 T3 DK1343480 T3 DK 1343480T3 DK 01992358 T DK01992358 T DK 01992358T DK 01992358 T DK01992358 T DK 01992358T DK 1343480 T3 DK1343480 T3 DK 1343480T3
Authority
DK
Denmark
Prior art keywords
active agents
phase transition
microparticles containing
induced phase
hydrophobic active
Prior art date
Application number
DK01992358T
Other languages
English (en)
Other versions
DK1343480T4 (da
Inventor
Celal Albayrak
Original Assignee
Alrise Biosystems Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26946029&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1343480(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Alrise Biosystems Gmbh filed Critical Alrise Biosystems Gmbh
Publication of DK1343480T3 publication Critical patent/DK1343480T3/da
Application granted granted Critical
Publication of DK1343480T4 publication Critical patent/DK1343480T4/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Colloid Chemistry (AREA)
DK01992358.0T 2000-12-21 2001-12-19 Induceret faseovergangsmetode til fremstilling af mikropartikler indeholdende hydrofobe aktive midler. DK1343480T4 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25752700P 2000-12-21 2000-12-21
US30002101P 2001-06-21 2001-06-21
PCT/US2001/050259 WO2002049620A2 (en) 2000-12-21 2001-12-19 Induced phase transition method for the production of microparticles containing hydrophobic active agents

Publications (2)

Publication Number Publication Date
DK1343480T3 true DK1343480T3 (da) 2007-08-06
DK1343480T4 DK1343480T4 (da) 2016-04-18

Family

ID=26946029

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01992358.0T DK1343480T4 (da) 2000-12-21 2001-12-19 Induceret faseovergangsmetode til fremstilling af mikropartikler indeholdende hydrofobe aktive midler.

Country Status (10)

Country Link
US (2) US7252842B2 (da)
EP (2) EP1343478B1 (da)
JP (2) JP2004516262A (da)
AT (2) ATE375145T1 (da)
AU (3) AU2002232824A1 (da)
CA (2) CA2432900C (da)
DE (2) DE60130917T2 (da)
DK (1) DK1343480T4 (da)
ES (2) ES2292634T3 (da)
WO (2) WO2002049620A2 (da)

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4241041B2 (ja) * 2000-12-07 2009-03-18 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング 酸分解性活性成分を含有するペースト形の医薬品製造物
ATE375145T1 (de) * 2000-12-21 2007-10-15 Alrise Biosystems Gmbh Induziertes phasenübergangs verfahren zur herstellung von hydrophile wirkstoffe enthaltende mikropartikeln
DE60222734T2 (de) * 2002-03-15 2008-07-17 Alrise Biosystems Gmbh Mikropartikel und Verfahren zur deren Herstellung
US8506617B1 (en) * 2002-06-21 2013-08-13 Advanced Cardiovascular Systems, Inc. Micronized peptide coated stent
US20040097419A1 (en) * 2002-11-19 2004-05-20 Holger Petersen Organic compounds
US8685428B2 (en) * 2002-12-10 2014-04-01 Advanced Cardiovascular Systems, Inc. Therapeutic composition and a method of coating implantable medical devices
US6887207B2 (en) * 2003-02-26 2005-05-03 Medtronic, Inc. Methods and apparatus for estimation of ventricular afterload based on ventricular pressure measurements
CA2520475C (en) * 2003-04-03 2012-10-09 Jessie L.-S. Au Tumor-targeting drug-loaded particles
GB0324086D0 (en) * 2003-10-14 2003-11-19 Glaxo Group Ltd Process for preparing a co-precipitate of a non-crystalline solid drug substance
DE10358461B4 (de) * 2003-12-13 2008-09-11 Man Roland Druckmaschinen Ag Gummierungsmedium
AU2005240078A1 (en) * 2004-04-30 2005-11-17 Allergan, Inc. Retinoid-containing sustained release intraocular drug delivery systems and related methods of manufacturing
WO2005112569A2 (en) * 2004-05-13 2005-12-01 Medtronic Vascular, Inc. Methods for compounding and delivering a therapeutic agent to the adventitia of a vessel
US20060057215A1 (en) * 2004-09-15 2006-03-16 Raiche Adrian T Method for the production of nanoparticles and microparticles by ternary agent concentration and temperature alteration induced immiscibility
US20090092650A1 (en) * 2004-12-15 2009-04-09 Warren Stephen L Sustained Delivery Formulations of Octreotide Compounds
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
ES2272156B1 (es) * 2005-04-18 2008-04-01 Italfarmaco, S.A. Sistemas microparticulares.
JP5067976B2 (ja) 2006-07-01 2012-11-07 オーパス ケイエスディー インコーポレイテッド 組織固定具ならびに関連する挿入デバイス、機構、および方法
EP3047860A1 (en) 2006-07-20 2016-07-27 OrbusNeich Medical, Inc. Bioabsorbable polymeric composition for a medical device
DK2049081T3 (da) 2006-08-09 2013-02-25 Intarcia Therapeutics Inc Osmotiske leveringssystemer og stempelarrangementer
JP5302888B2 (ja) * 2006-08-31 2013-10-02 エスケー ケミカルズ カンパニー リミテッド 薬物含有高分子微小球の製造方法及びその方法により製造された薬物含有高分子微小球
US8691321B2 (en) 2006-10-20 2014-04-08 Orbusneich Medical, Inc. Bioabsorbable polymeric composition and medical device background
US7959942B2 (en) 2006-10-20 2011-06-14 Orbusneich Medical, Inc. Bioabsorbable medical device with coating
US7887984B2 (en) * 2007-01-18 2011-02-15 Eastman Kodak Company Toner porous particles containing hydrocolloids
CA2683698C (en) 2007-04-19 2013-09-10 Hyun Hee Kwak A biodegradable microsphere composition suitable for the controlled release of glucose controlling peptide and formulation thereof
ES2402172T3 (es) 2007-04-23 2013-04-29 Intarcia Therapeutics, Inc Formulación en suspensión de péptidos insulinotrópicos y usos de los mismos
US8124601B2 (en) * 2007-11-21 2012-02-28 Bristol-Myers Squibb Company Compounds for the treatment of Hepatitis C
WO2009085952A1 (en) 2007-12-20 2009-07-09 Brookwood Pharmaceuticals, Inc. Process for preparing microparticles having a low residual solvent volume
EP2240155B1 (en) 2008-02-13 2012-06-06 Intarcia Therapeutics, Inc Devices, formulations, and methods for delivery of multiple beneficial agents
ES2569556T3 (es) * 2008-06-03 2016-05-11 Indivior Uk Limited Complejo de inclusión de hidrogel deshidratado de un agente bioactivo con sistema fluido de administración de medicamento
WO2010005726A2 (en) 2008-06-16 2010-01-14 Bind Biosciences Inc. Therapeutic polymeric nanoparticles with mtor inhibitors and methods of making and using same
PT2774608T (pt) 2008-06-16 2020-01-17 Pfizer Nanopartículas poliméricas carregadas com fármaco e métodos de produção e utilização das mesmas
EA020753B1 (ru) 2008-06-16 2015-01-30 Бинд Терапьютикс, Инк. Терапевтические полимерные наночастицы, содержащие алкалоиды vinca, и их применение
EP3685837A1 (en) * 2008-09-04 2020-07-29 Amylin Pharmaceuticals, LLC Sustained release formulations using non-aqueous carriers
JP2012512175A (ja) 2008-12-15 2012-05-31 バインド バイオサイエンシズ インコーポレイテッド 治療薬を徐放するための長時間循環性ナノ粒子
US20100291027A1 (en) * 2009-05-14 2010-11-18 Jason Campbell Hyaluronic acid (ha) injection vehicle
US9637408B2 (en) * 2009-05-29 2017-05-02 Corsam Technologies Llc Fusion formable sodium containing glass
CN107638562B (zh) 2009-09-28 2022-12-02 精达制药公司 基本稳态药物递送的快速建立和/或终止
US20110081420A1 (en) * 2009-10-07 2011-04-07 Zyga Technology, Inc. Method of forming prolonged-release injectable steroids
US8357401B2 (en) 2009-12-11 2013-01-22 Bind Biosciences, Inc. Stable formulations for lyophilizing therapeutic particles
US9295649B2 (en) * 2009-12-15 2016-03-29 Bind Therapeutics, Inc. Therapeutic polymeric nanoparticle compositions with high glass transition temperature or high molecular weight copolymers
WO2011163469A1 (en) 2010-06-23 2011-12-29 Teva Pharmaceutical Industries Ltd. Hydrated form of anti-inflammatory roflumilast-n-oxide
UA111162C2 (uk) 2010-08-04 2016-04-11 Флекшен Терап'Ютікс, Інк. Ін'єкційна композиція ацетоніду триамцинолону для лікування болю
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
ES2642312T3 (es) * 2011-08-04 2017-11-16 Flexion Therapeutics, Inc. Corticosteroides para el tratamiento del dolor de articulaciones
US8927619B2 (en) 2011-12-21 2015-01-06 Jorg Thomas Wilken Color-stabilized iodopropynyl butylcarbamate
MX356097B (es) 2012-09-17 2018-05-14 Pfizer Inc Star Proceso para la preparacion de nanoparticulas terapeuticas.
US9232943B2 (en) 2013-01-31 2016-01-12 Opus Ksd Inc. Delivering bioabsorbable fasteners
KR20160093611A (ko) * 2013-12-05 2016-08-08 알라이즈 바이오시스템즈 게엠베하 경구 투여를 위한 약물 제제의 제조 방법
PL3116547T3 (pl) 2014-03-14 2019-11-29 Pfizer Terapeutyczne nanocząstki zawierające środek terapeutyczny i sposoby ich wytwarzania i zastosowania
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
US9321899B1 (en) * 2014-10-29 2016-04-26 Xerox Corporation Preparing latex using a biosolvent
US10925639B2 (en) 2015-06-03 2021-02-23 Intarcia Therapeutics, Inc. Implant placement and removal systems
CA2987081C (en) * 2015-06-11 2022-08-30 Alrise Biosystems Gmbh Process for the preparation of drug loaded microparticles
BR112018073511A2 (pt) 2016-05-16 2019-03-26 Intarcia Therapeutics, Inc. polipeptídeos seletivos do receptor de glucagon e métodos de uso dos mesmos
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
IT201600123644A1 (it) * 2016-12-06 2018-06-06 I E T S P A Apparato di ripartizione selettiva della potenza di un veicolo plurimotorizzato
MX2019008006A (es) 2017-01-03 2019-08-29 Intarcia Therapeutics Inc Metodos que comprenden la administracion continua de un agonista del receptor de glp-1 y la co-administracion de un farmaco.
CN106719638A (zh) * 2017-01-04 2017-05-31 安徽国星生物化学有限公司 一种百草枯微胶囊悬浮剂及其制备方法
EP3372224A1 (en) * 2017-03-07 2018-09-12 Alrise Biosystems GmbH New controlled drug delivery system using water miscible solvents for production of drug loaded micro- and nanoparticles
KR102047983B1 (ko) 2017-11-30 2019-11-22 주식회사 지투지바이오 안전성 및 저장 안정성이 향상된 생분해성 미립구의 제조방법
CN109260173B (zh) * 2018-11-15 2019-08-20 朗天药业(湖北)有限公司 一种胸腺法新药物组合物及其制备方法
CN114349986B (zh) * 2021-12-28 2024-02-27 华熙生物科技股份有限公司 一种增加甘油粘度的方法和用途

Family Cites Families (92)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL280825A (da) 1962-07-11
BE744162A (fr) 1969-01-16 1970-06-15 Fuji Photo Film Co Ltd Procede d'encapsulage
DE2010115A1 (de) 1970-03-04 1971-09-16 Farbenfabriken Bayer Ag, 5090 Leverkusen Verfahren zur Herstellung von Mikrogranulaten
BE792550A (nl) 1971-12-23 1973-06-12 Agfa Gevaert Nv Procede voor het vervaardigen van microcapsules
JPS528795B2 (da) 1971-12-30 1977-03-11
JPS523342B2 (da) 1972-01-26 1977-01-27
GB1413186A (en) 1973-06-27 1975-11-12 Toyo Jozo Kk Process for encapsulation of medicaments
US4166800A (en) 1977-08-25 1979-09-04 Sandoz, Inc. Processes for preparation of microspheres
US4732763A (en) 1978-10-17 1988-03-22 Stolle Research And Development Corporation Active/passive immunization of the internal female reproductive organs
US4384975A (en) 1980-06-13 1983-05-24 Sandoz, Inc. Process for preparation of microspheres
US4389330A (en) † 1980-10-06 1983-06-21 Stolle Research And Development Corporation Microencapsulation process
US4675189A (en) 1980-11-18 1987-06-23 Syntex (U.S.A.) Inc. Microencapsulation of water soluble active polypeptides
US5366734A (en) 1981-02-16 1994-11-22 Zeneca Limited Continuous release pharmaceutical compositions
CH661206A5 (fr) 1983-09-23 1987-07-15 Debiopharm Sa Procede pour la preparation d'un medicament destine au traitement de maladies hormonodependantes.
JPS60100516A (ja) 1983-11-04 1985-06-04 Takeda Chem Ind Ltd 徐放型マイクロカプセルの製造法
US4568559A (en) 1984-02-06 1986-02-04 Biotek, Inc. Composite core coated microparticles and process of preparing same
US6410056B1 (en) * 1984-03-16 2002-06-25 The United States Of America As Represented By The Secretary Of The Army Chemotherapeutic treatment of bacterial infections with an antibiotic encapsulated within a biodegradable polymeric matrix
DE3678308D1 (de) 1985-02-07 1991-05-02 Takeda Chemical Industries Ltd Verfahren zur herstellung von mikrokapseln.
JP2551756B2 (ja) 1985-05-07 1996-11-06 武田薬品工業株式会社 ポリオキシカルボン酸エステルおよびその製造法
US4962091A (en) 1986-05-23 1990-10-09 Syntex (U.S.A.) Inc. Controlled release of macromolecular polypeptides
AU612591B2 (en) 1986-08-11 1991-07-18 Innovata Biomed Limited Pharmaceutical formulations comprising microcapsules
JPS63122620A (ja) 1986-11-12 1988-05-26 Sanraku Inc ポリ乳酸マイクロスフエア及びその製造方法
FR2608942B1 (fr) † 1986-12-31 1991-01-11 Centre Nat Rech Scient Procede de preparation de systemes colloidaux dispersibles d'une substance, sous forme de nanocapsules
US5690954A (en) 1987-05-22 1997-11-25 Danbiosyst Uk Limited Enhanced uptake drug delivery system having microspheres containing an active drug and a bioavailability improving material
US4897268A (en) 1987-08-03 1990-01-30 Southern Research Institute Drug delivery system and method of making the same
DE3738228A1 (de) 1987-11-11 1989-05-24 Hoechst Ag Verfahren zur herstellung von bioabbaubaren mikrokapseln wasserloeslicher peptide und proteine sowie nach diesem verfahren erhaltene mikrokapseln
JP2670680B2 (ja) 1988-02-24 1997-10-29 株式会社ビーエムジー 生理活性物質含有ポリ乳酸系微小球およびその製造法
US4902515A (en) 1988-04-28 1990-02-20 E. I. Dupont De Nemours And Company Polylactide compositions
DK0383047T3 (da) 1989-02-16 1994-06-27 Sig Schweiz Industrieges Indretning til passagertogvogne med UIC-træk- og stødindretninger, samt en sådan togvogn
US5019400A (en) 1989-05-01 1991-05-28 Enzytech, Inc. Very low temperature casting of controlled release microspheres
HU221294B1 (en) 1989-07-07 2002-09-28 Novartis Ag Process for producing retarde compositions containing the active ingredient in a polymeric carrier
US5271961A (en) 1989-11-06 1993-12-21 Alkermes Controlled Therapeutics, Inc. Method for producing protein microspheres
US5478564A (en) 1990-02-22 1995-12-26 Teva Pharmaceutical Industries, Ltd. Preparation of microparticles for controlled release of water-soluble substances
US6120805A (en) 1990-04-06 2000-09-19 Rhone-Poulenc Rorer Sa Microspheres, process for their preparation and their use
JP3116311B2 (ja) 1990-06-13 2000-12-11 エーザイ株式会社 マイクロスフィアの製法
NZ240214A (en) 1990-10-16 1993-02-25 Takeda Chemical Industries Ltd Polymer compositions comprising a polylactic acid and a copolymer of glycolic acid and a hydroxycarboxylic acid; use as carrier for prolonged release pharmaceutical compositions of water soluble drugs
IT1243390B (it) 1990-11-22 1994-06-10 Vectorpharma Int Composizioni farmaceutiche in forma di particelle atte al rilascio controllato di sostanze farmacologicamente attive e procedimento per la loro preparazione.
CH683149A5 (fr) 1991-07-22 1994-01-31 Debio Rech Pharma Sa Procédé pour la préparation de microsphères en matériau polymère biodégradable.
GB9116610D0 (en) 1991-08-01 1991-09-18 Danbiosyst Uk Preparation of microparticles
ATE154241T1 (de) 1991-10-01 1997-06-15 Takeda Chemical Industries Ltd Mikropartikeln-zusammenfassung zur verlängerten freigabe und herstellung derselbe
US5676968A (en) 1991-10-31 1997-10-14 Schering Aktiengesellschaft Transdermal therapeutic systems with crystallization inhibitors
DE4223169C1 (de) 1992-07-10 1993-11-25 Ferring Arzneimittel Gmbh Verfahren zur Mikroverkapselung wasserlöslicher Wirkstoffe
JP2651320B2 (ja) 1992-07-16 1997-09-10 田辺製薬株式会社 徐放性マイクロスフェア製剤の製造方法
AU4198793A (en) 1992-07-24 1994-01-27 Takeda Chemical Industries Ltd. Microparticle preparation and production thereof
FR2693905B1 (fr) 1992-07-27 1994-09-02 Rhone Merieux Procédé de préparation de microsphères pour la libération prolongée de l'hormone LHRH et ses analogues, microsphères et formulations obtenues.
US5661125A (en) 1992-08-06 1997-08-26 Amgen, Inc. Stable and preserved erythropoietin compositions
EP0582459B1 (en) 1992-08-07 1998-01-07 Takeda Chemical Industries, Ltd. Production of microcapsules of water-soluble drugs
WO1994008599A1 (en) 1992-10-14 1994-04-28 The Regents Of The University Of Colorado Ion-pairing of drugs for improved efficacy and delivery
ES2127835T3 (es) 1992-10-26 1999-05-01 Sanol Arznei Schwarz Gmbh Procedimiento para la preparacion de microcapsulas.
US5603960A (en) 1993-05-25 1997-02-18 O'hagan; Derek T. Preparation of microparticles and method of immunization
US5635216A (en) 1993-12-16 1997-06-03 Eli Lilly And Company Microparticle compositions containing peptides, and methods for the preparation thereof
US5500161A (en) 1993-09-21 1996-03-19 Massachusetts Institute Of Technology And Virus Research Institute Method for making hydrophobic polymeric microparticles
US5643605A (en) 1993-10-25 1997-07-01 Genentech, Inc. Methods and compositions for microencapsulation of adjuvants
US6080429A (en) 1993-10-25 2000-06-27 Genentech, Inc. Method for drying microspheres
US5650173A (en) 1993-11-19 1997-07-22 Alkermes Controlled Therapeutics Inc. Ii Preparation of biodegradable microparticles containing a biologically active agent
US5902565A (en) 1993-12-24 1999-05-11 Csl Limited Spray dried vaccine preparation comprising aluminium adsorbed immunogens
CA2143044C (en) 1994-02-21 2005-04-12 Yasutaka Igari Matrix for sustained-release preparation
DE4406172C2 (de) 1994-02-25 2003-10-02 Sanol Arznei Schwarz Gmbh Polyester
GB9406094D0 (en) 1994-03-28 1994-05-18 Univ Nottingham And University Polymer microspheres and a method of production thereof
FR2718642B1 (fr) 1994-04-15 1996-07-12 Pf Medicament Microsphères biodégradables à libération contrôlée et leur procédé de préparation.
JP3608625B2 (ja) 1994-05-15 2005-01-12 アメルシャム・バイオサイエンシーズ・アクチボラグ 粒子の製造方法、及び該方法によって製造され得る粒子
US6007845A (en) 1994-07-22 1999-12-28 Massachusetts Institute Of Technology Nanoparticles and microparticles of non-linear hydrophilic-hydrophobic multiblock copolymers
AU705968B2 (en) † 1995-06-07 1999-06-03 Alkermes Controlled Therapeutics, Inc. Device for releasing aggregation-stabilized, biologically active agent
US6143211A (en) * 1995-07-21 2000-11-07 Brown University Foundation Process for preparing microparticles through phase inversion phenomena
JP2909418B2 (ja) 1995-09-18 1999-06-23 株式会社資生堂 薬物の遅延放出型マイクロスフイア
DE19545257A1 (de) * 1995-11-24 1997-06-19 Schering Ag Verfahren zur Herstellung von morphologisch einheitlichen Mikrokapseln sowie nach diesem Verfahren hergestellte Mikrokapseln
CA2192782C (en) 1995-12-15 2008-10-14 Nobuyuki Takechi Production of microspheres
AU1354497A (en) 1995-12-21 1997-07-14 Drexel University Hollow polymer microcapsules and method of producing
US5985312A (en) 1996-01-26 1999-11-16 Brown University Research Foundation Methods and compositions for enhancing the bioadhesive properties of polymers
US5611344A (en) 1996-03-05 1997-03-18 Acusphere, Inc. Microencapsulated fluorinated gases for use as imaging agents
US5792477A (en) 1996-05-07 1998-08-11 Alkermes Controlled Therapeutics, Inc. Ii Preparation of extended shelf-life biodegradable, biocompatible microparticles containing a biologically active agent
GB2316316A (en) 1996-08-23 1998-02-25 Int Centre Genetic Eng & Bio Sustained release of erythropoietin from microspheres
US5766637A (en) 1996-10-08 1998-06-16 University Of Delaware Microencapsulation process using supercritical fluids
ATE272394T1 (de) 1996-10-31 2004-08-15 Takeda Chemical Industries Ltd Zubereitung mit verzögerter freisetzung
AUPO379596A0 (en) * 1996-11-22 1996-12-19 Soltec Research Pty Ltd Percutaneous delivery system
EP0959873B1 (en) 1996-12-20 2006-03-01 ALZA Corporation Gel composition and methods
US5976574A (en) * 1996-12-31 1999-11-02 Inhale Therapeutic Systems Processes for spray drying hydrophobic drugs in organic solvent suspensions
US5783567A (en) 1997-01-22 1998-07-21 Pangaea Pharmaceuticals, Inc. Microparticles for delivery of nucleic acid
US6048551A (en) 1997-03-27 2000-04-11 Hilfinger; John M. Microsphere encapsulation of gene transfer vectors
US6020004A (en) 1997-04-17 2000-02-01 Amgen Inc. Biodegradable microparticles for the sustained delivery of therapeutic drugs
SE512663C2 (sv) 1997-10-23 2000-04-17 Biogram Ab Inkapslingsförfarande för aktiv substans i en bionedbrytbar polymer
EP1028746B1 (en) † 1997-11-07 2003-02-26 Chiron Corporation Method for producing igf-i sustained-release formulations
US6197229B1 (en) 1997-12-12 2001-03-06 Massachusetts Institute Of Technology Method for high supercoiled DNA content microspheres
GB9810236D0 (en) 1998-05-13 1998-07-08 Microbiological Res Authority Improvements relating to encapsulation of bioactive agents
KR19990085365A (ko) 1998-05-16 1999-12-06 허영섭 지속적으로 약물 조절방출이 가능한 생분해성 고분자 미립구 및그 제조방법
WO2000004916A1 (en) 1998-07-23 2000-02-03 Societe De Conseils De Recherches Et D'applications Scientifiques Sas Encapsulation of water soluble peptides
DE69929904T2 (de) * 1998-11-18 2006-08-31 University Of Florida, Gainesville Methode zur herstellung von beschichteten partikeln und diese enthaltende pharmazeutische formulierungen
US6194006B1 (en) † 1998-12-30 2001-02-27 Alkermes Controlled Therapeutics Inc. Ii Preparation of microparticles having a selected release profile
DE19916384A1 (de) * 1999-03-31 2000-10-05 Schering Ag Cyproteronacetat, Chlormadinonacetat oder 17alpha-Propylmesterolon enthaltende, bioerosive Mikropartikeln, Verfahren zu deren Herstellung, therapeutische Verwendung dieser in topischen Arzneiformen
US6291013B1 (en) 1999-05-03 2001-09-18 Southern Biosystems, Inc. Emulsion-based processes for making microparticles
FR2797784B1 (fr) * 1999-08-27 2001-11-30 Mainelab Procede d'encapsulation de matieres actives par coacervation de polymeres en solvant organique non-chlore
ATE375145T1 (de) * 2000-12-21 2007-10-15 Alrise Biosystems Gmbh Induziertes phasenübergangs verfahren zur herstellung von hydrophile wirkstoffe enthaltende mikropartikeln

Also Published As

Publication number Publication date
DE60128261D1 (de) 2007-06-14
DE60130917T2 (de) 2008-07-17
AU2002232824A1 (en) 2002-07-01
ES2286157T3 (es) 2007-12-01
EP1343480B2 (en) 2016-02-17
EP1343480B1 (en) 2007-05-02
DE60130917D1 (de) 2007-11-22
US7252842B2 (en) 2007-08-07
JP2004516262A (ja) 2004-06-03
WO2002049619A3 (en) 2002-12-05
WO2002049620A3 (en) 2003-05-15
EP1343478A2 (en) 2003-09-17
WO2002049619A2 (en) 2002-06-27
ES2292634T3 (es) 2008-03-16
CA2432900A1 (en) 2002-06-27
WO2002049620A2 (en) 2002-06-27
WO2002049619A9 (en) 2006-05-18
EP1343480A2 (en) 2003-09-17
JP2004516263A (ja) 2004-06-03
US20030068381A1 (en) 2003-04-10
ATE361057T1 (de) 2007-05-15
CA2432904C (en) 2007-09-11
ATE375145T1 (de) 2007-10-15
CA2432904A1 (en) 2002-06-27
US6899898B2 (en) 2005-05-31
DK1343480T4 (da) 2016-04-18
ES2286157T5 (es) 2016-05-12
CA2432900C (en) 2007-09-11
DE60128261T2 (de) 2008-01-10
EP1343478B1 (en) 2007-10-10
AU2002235253A8 (en) 2005-10-06
US20020192294A1 (en) 2002-12-19
AU2002235253A1 (en) 2002-07-01
DE60128261T3 (de) 2016-06-30

Similar Documents

Publication Publication Date Title
DK1343480T3 (da) Induceret faseovergangsmetode til fremstilling af mikropartikler indeholdende hydrofobe aktive midler
ES2154737T3 (es) Proceso para preparar formas de dosificacion farmaceutica solidas de substancias hidrofobicas.
DE60238335D1 (de) Gerüstprodukt für die konstruktion von menschlichem knochengewebe, verfahren zu seiner herstellung
ATE556059T1 (de) Pyrazolderivate zur behandlung von hiv
ATE334662T1 (de) Herstellungsverfahren von arzneizubereitungen
DOP2001000238A (es) Proceso para la fabricacion de acidos n-aril-antrani- licos y sus derivados (process for making-aryl- anthranilic acids and their)
DE60043305D1 (de) Pharmazeutische zubereitungen zur behandlung von insulinresitenz
HUP0203028A2 (hu) Tolterodint tartalmazó gyógyszerkészítmény és alkalmazása
ATE296628T1 (de) Integrinhemmer zur behandlung von augenkrankheiten
DE60230438D1 (de) Racemat von tamsulosin als freie base und dessen herstellungsverfahren
ATE442852T1 (de) Trimetazidine enthaltendes arzneimittel mit verzögerter wirkstoffabgabe und verfahren zur herstellung
ATE355062T1 (de) Retard-zubereitungen von chinolon-antibiotika und verfahren zu ihrer herstellung
NO20035458D0 (no) Virkestoffkombinasjon av for eksempel galantamin eller desoksypeganin og for eksempel acamprosat eller memantin for behandling av enavhengighet slik som alkoholisme
IT1318524B1 (it) Composizioni a rilascio controllato contenenti un principio attivo,preferibilmente melatonina, e processo di preparazione delle stesse.
DE50211023D1 (de) Enzymatische synthese von zuckeracrylaten
DK1395231T3 (da) Præparat til fjernelse af abnormt keratinmateriale
MX9101958A (es) Inhibidores de acat de urea de aminosulfonilo
CL2008003111A1 (es) Procedimiento para preparar hemihidrato de nevirapina y procedimiento para preparar una suspension acuosa de hemihidrato de nevirapina (div. sol. 2051-1998).
ATE329910T1 (de) 5-trityloxymethyl-2-oxazolidinon und verfahren zu dessen herstellung
EA200200294A1 (ru) Сферические агломераты телитромицина, способ их получения и их применение для приготовления лекарственных форм
UA50173A (uk) Інтегрована комунікаційна система як розділ системи забезпечення життєдіяльності людини та машини, спосіб її створення і пристрій
AR019466A1 (es) Un proceso para preparar microesferas polimericas que comprenden un polimero y un peptido y una microesfera polimerica
DE69804766T2 (de) Isoflavonderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
DE60105627D1 (de) Verfahren zur tabletten-herstellung
BR0109433A (pt) Substância farmacêutica cristalina